Synthesis, anticancer, and docking of new thiadiazolyl-triazole analogues hybridized with thiazolidinone/thiophene
作者:Menier Al-Anazi
DOI:10.1016/j.molstruc.2022.134864
日期:2023.4
4-thiadiazol-2-yl)-2H-1,2,3-triazole-4-carboxamide compound 5 with ammonium thiocyanate. The introduction of thiophene ring system into the thiadiazole-triazole analogue is achieved by heterocyclizing the key chloroacetamide 5 with various thiocarbamoyl reagents 8 and 10 to yield the corresponding thiadiazole-triazole-thiophene hybrids 9 and 11, respectively. Further, in vitro MTT cytotoxic screening against four dissimilar
噻二唑-三唑-噻唑烷酮杂化物6和7a-c的合成方案基于前体噻二唑-三唑类似物4的氯乙酰化,然后环化产生的 5-(2-氯乙酰氨基)-2-苯基- N -(1,3 ,4-thiadiazol-2-yl)-2 H -1,2,3-triazole-4-carboxamide 化合物5与硫氰酸铵。通过将关键的氯乙酰胺5与各种硫代氨基甲酰试剂8和10杂环化,得到相应的噻二唑-三唑-噻吩杂化物9和11,分别。此外,与参考药物 5-Fu 相比,评估了针对四种不同细胞系(包括 HepG2、MCF-7、PC3 和 Hep-2)的体外MTT 细胞毒性筛选。结果证明了对癌细胞系的不同疗效,显示出对 MCF-7 和 HepG-2 的细胞毒性选择性。发现噻二唑-三唑杂化物 7a-c、9a、9b、11a和11b是这些衍生物中对抗 MCF-7 和 HepG-2 癌细胞最有效的药物。其中,混合7c显示出最有效的 IC 50针对